Clinical Trial Update: A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of varespladib infusion in sickle cell disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Varespladib (varespladib)

Snippet

Sponsor: Anthera Pharmaceuticals | Conditions: Sickle Cell Disease, Vaso-occlusive Crisis | Phase 2 | Status: TERMINATED